Literature DB >> 2541163

In vitro study of mediators of inflammation in multiple sclerosis.

J E Merrill1, S R Strom, G W Ellison, L W Myers.   

Abstract

Prostaglandin E levels have previously been demonstrated to be elevated in multiple sclerosis (MS). We have further investigated other products of activated macrophages related to inflammation. We report here on prostaglandin E and its relationship to interleukin 1, tumor necrosis factor, and leukotriene B4 produced by macrophages from blood and cerebrospinal fluid of MS patients and controls in vitro. Interleukin and tumor necrosis factor are elevated significantly after stimulation in MS, while leukotriene B4 production by blood macrophages is depressed compared to other neurological disease and normal healthy controls. In 40% of MS patients tested, peripheral blood macrophages spontaneously produced elevated levels of interleukin 1. All mediators of inflammation are produced in increased amounts by MS cerebrospinal fluid leukocytes after stimulation. Macrophages from MS blood are not as sensitive as controls to nonsteroidal inhibitors specific for lipoxygenase or cyclo-oxygenase pathways. Positive correlations of elevations in production of such mediators of inflammation as prostaglandin E, interleukin 1, and tumor necrosis factor in MS were significant. Elevated production of these mediators in combination with insensitivity to inhibitors of inflammation suggests a role for activated macrophages in the demyelination process.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541163     DOI: 10.1007/bf00916935

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  52 in total

1.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

3.  Prostaglandin release in multiple sclerosis: correlation with disease activity.

Authors:  P Dore-Duffy; J O Donaldson; T Koff; M Longo; W Perry
Journal:  Neurology       Date:  1986-12       Impact factor: 9.910

4.  Effects of soluble stimuli on human monocyte secretion.

Authors:  S C Speziale; R J Smith
Journal:  Clin Immunol Immunopathol       Date:  1985-07

5.  Multiple sclerosis patients show an increased spontaneous activity of their peripheral blood monocytes as measured by chemiluminescence.

Authors:  K P Hammann; W Nix; M P Dierich; H C Hopf
Journal:  Acta Neurol Scand       Date:  1983-09       Impact factor: 3.209

6.  Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. Part 2. Effect of exogenous PGE1 on spontaneous and interferon-induced natural killer.

Authors:  J E Merrill; L W Myers; G W Ellison
Journal:  J Neuroimmunol       Date:  1983-06       Impact factor: 3.478

7.  Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. Part 1. Association between amount of prostaglandin produced, natural killer, and endogenous interferon.

Authors:  J E Merrill; R H Gerner; L W Myers; G W Ellison
Journal:  J Neuroimmunol       Date:  1983-06       Impact factor: 3.478

8.  Pyrogen fever and prostaglandin-like activity in cerebrospinal fluid.

Authors:  W Feldberg; K P Gupta
Journal:  J Physiol       Date:  1973-01       Impact factor: 5.182

9.  Modes of action of aspirin-like drugs.

Authors:  S Abramson; H Korchak; R Ludewig; H Edelson; K Haines; R I Levin; R Herman; L Rider; S Kimmel; G Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

10.  Cytotoxic activity of peripheral blood and cerebrospinal fluid lymphocytes from patients with multiple sclerosis and other neurological diseases: analysis at the single cell level of the relationship of cytotoxic effectors and interferon-producing cells.

Authors:  J E Merrill; G W Ellison; L W Myers
Journal:  Clin Immunol Immunopathol       Date:  1984-06
View more
  14 in total

Review 1.  G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Authors:  Changsheng Du; Xin Xie
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617

Review 2.  Immune modulating peptides for the treatment and suppression of multiple sclerosis.

Authors:  Ahmed H Badawi; Teruna J Siahaan
Journal:  Clin Immunol       Date:  2012-06-05       Impact factor: 3.969

3.  Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.

Authors:  K Selmaj; C S Raine; B Cannella; C F Brosnan
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

4.  Tumour necrosis factor-alpha synthesis by cerebrospinal-fluid-derived T cell clones from patients with multiple sclerosis.

Authors:  R Benvenuto; M Paroli; C Buttinelli; A Franco; V Barnaba; C Fieschi; F Balsano
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

5.  Tumour necrosis factor alpha is elevated in serum and cerebrospinal fluid in multiple sclerosis and inflammatory neuropathies.

Authors:  M Rentzos; C Nikolaou; A Rombos; K Voumvourakis; I Segditsa; C Papageorgiou
Journal:  J Neurol       Date:  1996-02       Impact factor: 4.849

6.  Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1.

Authors:  J E Merrill; Y Koyanagi; J Zack; L Thomas; F Martin; I S Chen
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

7.  Gamma interferon cooperates with lipopolysaccharide to activate mouse splenic macrophages to an antihistoplasma state.

Authors:  T E Lane; B A Wu-Hsieh; D H Howard
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

Review 8.  Cytokines and autoimmunity.

Authors:  M G Cavallo; P Pozzilli; R Thorpe
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

Review 9.  Autoimmune disease and the nervous system. Biochemical, molecular, and clinical update.

Authors:  J E Merrill; M C Graves; D G Mulder
Journal:  West J Med       Date:  1992-06

Review 10.  Production, regulation and role of nitric oxide in glial cells.

Authors:  V A Vincent; F J Tilders; A M Van Dam
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.